Tag Archives: biotechnology law

Defining the Abstract and Conceptual – USPTO Issues “Guidance” Post-Bilski

Before I write another word, I want to recognize and applaud the intellectual and logistical effort it must have taken for Director Kappos and his helpers to put together six pages of “Interim Guidance For Determining Subject Matter Eligibility for … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | 1 Comment

Rader’s Dissent in Bilski – Keeping It Real

Discussing a particularly convincing dissent, commentators frequently are compelled to close with: “But it was a dissent.” The most influential dissent in recent months may well be Judge Rader’s dissent in In re Bilski, 545 F.3d 943, 1011 (Fed. Cir. 2008). … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Prometheus v. Mayo and Classen v. Biogen Sent Back to Federal Circuit

  Not unexpectedly, today the Supreme Court granted cert. in Prometheus v. Mayo, (09-490) vacated, and remanded to the Fed. Cir. for reconsideration in view of Bilski v. Kappos, decided yesterday. While this clears the Court’s collective desk, I don’t … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Collins On Human Genome Project – “We’ve Only Just Begun”

In a Reuters story posted yesterday, Francis Collins, one of the directors of the Human Genome Project, was asked if the Project had lived up to the hype that accompanied the sequencing of the entire human genome ten years ago. … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment